Trientine Tetrahydrochloride Patent Expiration

Trientine Tetrahydrochloride is Used for the treatment of stable Wilson's disease in adult patients who are already de-coppered and tolerant to penicillamine. It was first introduced by Orphalan Sa in its drug Cuvrior on Apr 28, 2022.


Trientine Tetrahydrochloride Patents

Given below is the list of patents protecting Trientine Tetrahydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Cuvrior US10988436 Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use May 03, 2039 Orphalan
Cuvrior US11072577 Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use May 03, 2039 Orphalan


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳